Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biological OviTex Versus Synthetic Graft in Robotic Prolapse Surgery: a Multicentre, Phase 11-111, Partially Randomised Patient Preference Trial

NCT06430931 is registered in ClinicalTrials.gov with Meander Medical Center as lead sponsor.

NCT NCT06430931
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06430931 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biological OviTex Versus Synthetic Graft in Robotic Prolapse Surgery: a Multicentre, Phase 11-111, Partially Randomised Patient Preference Trial
Lead sponsor
Meander Medical Center
Phase
Not applicable
Overall status
Recruiting
Start date
December 6, 2023
Completion date
July 1, 2027
Enrollment
184 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal disorders, cystocele, enterocele, prolapse, prolapse bladder, prolapse genital, prolapse pelvic, prolapse rectal, prolapse uterus, prolapse; cervix, rectocele